Filing Details

Accession Number:
0001453687-20-000110
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-08 17:50:37
Reporting Period:
2020-10-06
Accepted Time:
2020-10-08 17:50:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055624 A Timothy Springer 36 Woodman Road
Chestnut Hill MA 02467
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-06 2,000,000 $1.68 7,486,463 No 4 P Indirect See Footnote
Common Stock Acquisiton 2020-10-07 654,953 $1.65 8,141,416 No 4 P Indirect See Footnote
Common Stock Acquisiton 2020-10-08 530,441 $1.89 8,671,857 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,293,625 Direct
Common Stock 86,418 Indirect By wife
Footnotes
  1. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.605 to $1.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
  3. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.55 to $1.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  4. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.799 to $1.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.